Pictet - Biotech - HP CHF/ LU0843168732 /
| NAV04/11/2024 | Diferencia+3.8800 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 679.8100CHF | +0.57% | reinvestment | Equity Worldwide | Pictet AM (EU) ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012 | - | - | - | - | - | - | - | - | - | - | - | -1.70 | - |
| 2013 | 7.42 | 0.45 | 7.42 | 6.54 | 2.79 | -4.28 | 12.02 | -0.08 | 8.56 | -5.20 | 7.32 | 2.00 | +53.23% |
| 2014 | 9.16 | 7.10 | -10.17 | -7.06 | 1.51 | 7.76 | -2.34 | 8.02 | -1.75 | 8.25 | 2.54 | -0.06 | +22.77% |
| 2015 | 6.66 | 5.29 | 1.54 | -4.98 | 11.06 | 1.77 | 3.05 | -9.56 | -10.38 | 4.89 | 3.08 | -0.15 | +10.43% |
| 2016 | -22.33 | -6.09 | 4.03 | 3.08 | 4.11 | -8.04 | 12.09 | -4.70 | 1.66 | -10.94 | 7.39 | -3.76 | -25.15% |
| 2017 | 6.49 | 7.08 | -1.09 | 1.75 | -4.49 | 9.12 | 2.49 | 4.67 | -0.28 | -6.93 | -0.32 | 2.06 | +21.15% |
| 2018 | 6.51 | -5.40 | -2.50 | -3.80 | 3.92 | 1.08 | 3.50 | 3.35 | -1.73 | -13.90 | 2.10 | -10.15 | -17.56% |
| 2019 | 14.40 | 4.07 | -1.51 | -3.91 | -4.27 | 8.20 | 0.08 | -5.79 | -5.93 | 7.75 | 13.18 | 0.10 | +26.36% |
| 2020 | -4.42 | -2.50 | -4.50 | 17.20 | 5.21 | 1.84 | -1.20 | 0.16 | 5.75 | -3.48 | 7.00 | 3.84 | +25.45% |
| 2021 | 3.68 | -3.15 | -4.15 | 1.64 | -4.72 | 4.14 | -1.86 | 4.50 | -3.32 | -2.24 | -6.26 | 2.25 | -9.82% |
| 2022 | -18.68 | -2.50 | 3.39 | -10.02 | -4.14 | 4.54 | 5.93 | 4.40 | -2.44 | 1.83 | 4.14 | -3.28 | -18.20% |
| 2023 | 2.28 | -4.59 | -3.01 | 4.98 | -0.39 | 0.44 | 0.19 | -1.30 | -5.14 | -11.76 | 11.90 | 18.05 | +8.69% |
| 2024 | 1.27 | 5.28 | -3.75 | -8.19 | 1.84 | 6.40 | 5.66 | 0.09 | -3.82 | -0.52 | 0.57 | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 21.44% | 20.06% | 23.17% | 25.85% | 25.20% |
| Índice de Sharpe | 0.07 | 0.40 | 1.08 | -0.32 | -0.01 |
| El mes mejor | +18.05% | +6.40% | +18.05% | +18.05% | +18.05% |
| El mes peor | -8.19% | -3.82% | -8.19% | -18.68% | -18.68% |
| Pérdida máxima | -15.82% | -10.35% | -15.82% | -40.23% | -47.40% |
| Rendimiento superior | +7.81% | - | +9.16% | -0.65% | -19.80% |
Todas las cotizaciones en CHF
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Pictet - Biotech - I USD | reinvestment | 1,167.0300 | +34.95% | -1.10% | |
| Pictet - Biotech - I EUR | reinvestment | 1,071.2300 | +32.96% | +4.74% | |
| Pictet - Biotech - HI EUR | reinvestment | 628.8200 | +32.12% | -8.53% | |
| Pictet - Biotech - I dy GBP | paying dividend | 899.8700 | +28.86% | +2.93% | |
| Pictet-Biotech Z | reinvestment | 1,322.7100 | +36.30% | +1.90% | |
| Pictet - Biotech - HZ CHF | reinvestment | 1,071.4500 | +30.25% | - | |
| Pictet - Biotech - P dy USD | paying dividend | 964.5300 | +33.76% | -3.72% | |
| Pictet - Biotech - HP EUR | reinvestment | 581.8500 | +30.96% | -10.96% | |
| Pictet - Biotech - P EUR | reinvestment | 885.2700 | +31.79% | +1.97% | |
| Pictet - Biotech - R USD | reinvestment | 824.2000 | +32.82% | -5.72% | |
| Pictet - Biotech - R EUR | reinvestment | 756.0700 | +30.86% | -0.16% | |
| Pictet - Biotech - HR EUR | reinvestment | 496.9100 | +30.04% | -12.82% | |
| Pictet - Biotech - P dy GBP | paying dividend | 743.2900 | +27.72% | +0.21% | |
| Pictet - Biotech - HP CHF | reinvestment | 679.8100 | +27.83% | -14.55% | |
| Pictet - Biotech - HR AUS | reinvestment | 792.0500 | +30.31% | - | |
| Pictet - Biotech - HR dm ZAR | paying dividend | 7,914.2700 | +35.32% | - | |
| Pictet - Biotech - P USD | reinvestment | 964.8900 | +33.76% | -3.71% |
Performance
| Año hasta la fecha | +3.89% | ||
|---|---|---|---|
| 6 Meses | +5.41% | ||
| Promedio móvil | +27.83% | ||
| 3 Años | -14.55% | ||
| 5 Años | +15.56% | ||
| 10 Años | +12.84% | ||
| Desde el principio | +100.64% | ||
| Año | |||
| 2023 | +8.69% | ||
| 2022 | -18.20% | ||
| 2021 | -9.82% | ||
| 2020 | +25.45% | ||
| 2019 | +26.36% | ||
| 2018 | -17.56% | ||
| 2017 | +21.15% | ||
| 2016 | -25.15% | ||
| 2015 | +10.43% | ||
